31
Jan
Jan
The American Food and Drug Administration (FDA) approved Suzetriga, a new non -porosity analgesic drug sold under the JournaVX brand, in order to treat moderate to severe acute acute pain in adults. Journavx with Vertex Pharmaceuticals means the first new class of painkillers that received FDA consent in over two decades. It will be sold […]